1 withdrawn. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Withdrawn 1 |
Follow Echothiophate Iodide 0.03% Ophthalmic Solution: new trials by email Literature Review of Echothiophate Iodide 0.03% Ophthalmic Solution trials Research Report on Echothiophate Iodide 0.03% Ophthalmic Solution
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Echothiophate Iodide for the Prevention of Progression of Myopia Echothiophate Iodide 0.03% Ophthalmic Solution, Carboxymethylcellulose Sodium (0.5%) - Myopia | Phase 4 | Withdrawn | Danbury Eye Physicians & Surgeons, PC | 2016-06-01 | 2025-02-07 |
Myopia (1)
Danbury Eye Physicians & Surgeons, PC (1)
United States (1)